Here are six takeaways:
1. An increasing geriatric population, rising healthcare requirements across the globe and an increasing number of orthopedic and cardiovascular disorders among the aged population are spurring the market’s growth.
2. Government initiatives to create healthcare infrastructure as well as rising investments for research and development also drive the market’s growth.
3. By 2020, the market is projected to reach $1.13 billion.
4. In 2013, implants accounted for 60 percent of the global market share.
5. North America accounted for more than 35 percent of the global revenue in 2013.
6. Key players include Envision TEC, Materialise, Stratasys, 3D Systems Software, Organovo, Bio-Rad Laboratories, SOLS, Metamason, Simbionix, RegenHU, Youbionic, 3D Matters Pte, 3D Systems, Roche Pharmaceuticals, Ekso Bionics, Renishaw, Delcam India, Robohand, Worrell, Archam, ALD Vacuum Technologies and Rainbow Biosciences.
More healthcare news:
7 things for ASC leaders to know for Monday — March 21, 2016
6 findings on Healthcare M&A in 2014
Columbus Eye Surgery Center celebrates 20 years — 3 highlights
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
